Insider Selling: ASP Isotopes (NASDAQ:ASPI) COO Sells 67,500 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) COO Robert Ainscow sold 67,500 shares of ASP Isotopes stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $1.57, for a total value of $105,975.00. Following the completion of the transaction, the chief operating officer directly owned 2,158,441 shares in the company, valued at approximately $3,388,752.37. This represents a 3.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

  • On Wednesday, October 14th, Robert Ainscow sold 22,500 shares of ASP Isotopes stock. The shares were sold at an average price of $2.11, for a total value of $47,475.00.
  • On Tuesday, September 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The shares were sold at an average price of $4.29, for a total value of $36,199.02.
  • On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The stock was sold at an average price of $3.90, for a total transaction of $97,500.00.

ASP Isotopes Trading Down 10.2%

Shares of ASP Isotopes stock opened at $1.23 on Thursday. The company’s fifty day simple moving average is $2.41 and its 200-day simple moving average is $4.50. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. ASP Isotopes Inc. has a 1 year low of $1.19 and a 1 year high of $8.60.

Analyst Upgrades and Downgrades

ASPI has been the subject of a number of research reports. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $12.00.

Check Out Our Latest Report on ASP Isotopes

Hedge Funds Weigh In On ASP Isotopes

Large investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company grew its holdings in shares of ASP Isotopes by 8.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock worth $135,000 after purchasing an additional 2,470 shares in the last quarter. Sanctuary Advisors LLC increased its position in shares of ASP Isotopes by 22.2% during the first quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company’s stock valued at $109,000 after purchasing an additional 4,465 shares during the period. Voya Investment Management LLC raised its stake in shares of ASP Isotopes by 24.3% in the third quarter. Voya Investment Management LLC now owns 27,468 shares of the company’s stock valued at $73,000 after purchasing an additional 5,377 shares in the last quarter. Royal Bank of Canada raised its stake in shares of ASP Isotopes by 18.4% in the first quarter. Royal Bank of Canada now owns 37,954 shares of the company’s stock valued at $167,000 after purchasing an additional 5,906 shares in the last quarter. Finally, State of Wyoming acquired a new position in shares of ASP Isotopes in the first quarter valued at $29,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.

Recommended Stories

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.